Compare ANGX & EVMN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ANGX | EVMN |
|---|---|---|
| Founded | 2013 | 2020 |
| Country | | |
| Employees | N/A | N/A |
| Industry | Movies/Entertainment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 571.7M | 529.6M |
| IPO Year | N/A | N/A |
| Metric | ANGX | EVMN |
|---|---|---|
| Price | $3.32 | $28.71 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 3 | 8 |
| Target Price | $10.67 | ★ $44.17 |
| AVG Volume (30 Days) | 692.6K | ★ 913.2K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | $220.89 | $89.43 |
| Revenue Next Year | $35.71 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.99 | $13.89 |
| 52 Week High | $18.90 | $33.20 |
| Indicator | ANGX | EVMN |
|---|---|---|
| Relative Strength Index (RSI) | 38.90 | 61.97 |
| Support Level | $3.13 | $15.97 |
| Resistance Level | $3.43 | $33.16 |
| Average True Range (ATR) | 0.31 | 3.56 |
| MACD | 0.01 | 1.05 |
| Stochastic Oscillator | 30.91 | 71.62 |
Angel Studios Inc is an entertainment company known for crowd-funded films and television projects. It enables creators to share projects and engage audiences directly. The platform allows fans to invest in and promote productions, fostering a community-driven approach to content creation.
Evommune Inc is a clinical-stage biotechnology company focused on creating new therapies aimed at key factors driving chronic inflammatory diseases. The initial clinical programs of the company target chronic spontaneous urticaria (CSU), atopic dermatitis (AD), and ulcerative colitis (UC). The pipeline products of the company include EVO756 and EVO301.